Searchable abstracts of presentations at key conferences in endocrinology

ea0049s2.1 | Evolving diagnostics in adrenal and neuroendocrine tumours | ECE2017

Role of genetic and biomarker tests for diagnosis of neuroendocrine tumours (NETs)

Thakker Raj

Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms that occur in different organs and give rise to tumours including carcinoids, pancreatic tumours (PNETs), pituitary adenomas, medullary thyroid carcinoma, and phaeochromocytomas. NETs usually occur as isolated non-familial tumours, but can also occur as hereditary and syndromic disorders, such as multiple endocrine neoplasia (MEN types 1–4), Von Hippel Lindau (VHL) and phaeochromocytoma/paraganglioma. Pa...

ea0068p16 | Abstracts | UKINETS2019

Clinical characteristics and outcomes of 23 patients with insulinoma: a single centre retrospective observational study 2011–2018

Healy Ultan , Tadman Michael , Weaver Andrew , Fryer Eve , Bailey Adam , Patel Neel , Boardman Phil , Soonawalla Zahir , Pal Aparna , May Christine JH , Thakker Raj V , Grossman Ashley B , Jafar-Mohammadi Bahram

We report a retrospective, single centre observational study to determine the characteristics and outcomes of pancreatic insulinoma. Interrogation of the Oxford NET database, a departmental database of new NET MDT referrals since 2011 (n = 1059), revealed 23/1059 (2.1%) patients with insulinoma diagnosed and treated between 2011 and 2018. Patient records were reviewed and data was captured on demographics, presentation, investigations, treatments and outcomes: 15/23 (...